The effect of Dienogest and GnRH agonist on pelvic pain & pregnancy outcome after laparoscopic surgery in endometriosis

Evaluation of the effect of Dienogest and GnRH agonist on pelvic pain & pregnancy outcome after laparoscopic surgery in endometriosis

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20091012002576N25

Enrollment

104

Registered

2022-03-02

Start date

2022-03-06

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis. Female infertility of other origin

Interventions

Intervention 1: Intervention group: After laparoscopic surgery for Deep infilterating endometriosis tablet Dienogest 2mg/day for three months willbe used. Intervention 2: Control group: After laparos

Eligibility

Sex/Gender

Female

Age

20 Years to 42 Years

Inclusion criteria

Inclusion criteria: Endometriosis deep infilterating endometriosis Infertility

Exclusion criteria

Exclusion criteria: Hypersensitivity to dinogest or Gnrh_agonist

Design outcomes

Primary

Measure	Time frame
Evaluation of dysmenorrhoea &dysparunia and Dyschezia. Timepoint: Thre months adter surgery. Method of measurement: Questionnaire for female sexual function index and Questionnaire for visual acuity scale.;Chemical pregnancy. Timepoint: Two weeks after embryo transfer. Method of measurement: Positive BhCG.	—

Secondary

Measure	Time frame
Clinical pregnancy. Timepoint: Four weeks after embryo transfer. Method of measurement: Vaginal ultrasound.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Davari Tanha

Tehran University of Medical Sciences

Fatedavtanha@gmail.com+98 21 8880 0115

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026